Black Diamond Therapeutics, Inc. (BDTX) vs Coya Therapeutics, Inc. (COYA)

Black Diamond Therapeutics, Inc. and Coya Therapeutics, Inc. are both Biotechnology companies. Black Diamond Therapeutics, Inc. and Coya Therapeutics, Inc. are of similar size ($101.8M and $100.0M). Black Diamond Therapeutics, Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 13 metrics below, Black Diamond Therapeutics, Inc. leads on 9 and Coya Therapeutics, Inc. on 4.

Valuation

Metric BDTX COYA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 12.49 9.71
P/B 1.03 2.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.23 n/m 0.64
EV/Sales n/m 8.72 9.21
Earnings yield (43.60%) (25.06%) (33.15%)
Free cash flow yield (33.25%) (17.74%) (25.50%)

Profitability

Metric BDTX COYA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (288.70%) 0.00%
Net margin 0.00% (270.22%) 0.00%
Free cash flow margin 0.00% (221.64%) 0.00%
Return on equity (37.21%) (60.54%) (56.36%)
Return on assets (29.21%) (53.66%) (48.04%)
Return on invested capital 0.00% (15,230.92%) 0.00%

Growth

Metric BDTX COYA Biotechnology median
Revenue growth (TTM) — 108.35% 6.02%
EPS growth (last fiscal year) 130.71% (29.59%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDTX COYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.28 13.40 4.72
Net debt to EBITDA (10.01) 2.08 0.96

Dividend

Metric BDTX COYA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BDTX COYA Biotechnology median
Market cap 99.97m 101.80m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack